CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,232,854
- in 4 filings, $918K under 10b5-1 plans
Net −$1,232,854. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-03-16 | PETERS WILLIAM J CFO, SVP & Treasurer | Grant or award · Employee Stock Option (right to buy) | +84,064 | 84,064 | ||
| 2017-03-16 | Shandell Jason B. President and General Counsel | Grant or award | +63,670 | 266,871 | ||
| 2017-03-16 | Shandell Jason B. President and General Counsel | Grant or award · Employee Stock Option (right to buy) | +158,784 | 158,784 | ||
| 2017-03-16 | Zhang Jack Y. CEO & Chief Scientific Officer | Grant or award | +156,554 | 1,244,889 | ||
| 2017-03-16 | Zhang Jack Y. CEO & Chief Scientific Officer | Grant or award | +67,415 | 819,736 | ||
| 2017-03-16 | Zhang Jack Y. CEO & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +490,477 | 490,477 | ||
| 2017-03-16 | Zhang Jack Y. CEO & Chief Scientific Officer | Grant or award · Employee Stock Option (right to buy) | +211,213 | 211,213 | ||
| 2017-01-03 | Petersen Floyd F. Director | Sale | −400 | $18.61 | $7K | 58,717 |
| 2016-12-15 | Gerst Diane G. EVP, QA & Regulatory Affairs | Sale | −2,940 | $20.51 | $60K | 26,195 |
| 2016-12-05 | Zhou Rong EVP, Production Center | Sale | −61 | $20.70 | $1K | 36,991 |
| 2016-12-01 | Petersen Floyd F. Director | Sale | −400 | $20.26 | $8K | 59,117 |
| 2016-11-28 | Shandell Jason B. President and General Counsel | Option exercise | +24,292 | $10.93 | $266K | 227,253 |
| 2016-11-28 | Shandell Jason B. President and General Counsel | Sale | −24,292 | $20.47 | $497K | 202,961 |
| 2016-11-28 | Shandell Jason B. President and General Counsel | Option exercise · Employee Stock Option (right to buy) | −24,292 | 68,657 | ||
| 2016-11-25 | Shandell Jason B. President and General Counsel | Option exercise | +2,043 | $10.93 | $22K | 205,004 |
| 2016-11-25 | Shandell Jason B. President and General Counsel | Sale | −2,043 | $20.59 | $42K | 202,961 |
| 2016-11-25 | Shandell Jason B. President and General Counsel | Option exercise · Employee Stock Option (right to buy) | −2,043 | 92,949 | ||
| 2016-11-15 | Lee Howard Director | Option exercise | +17,994 | $14.23 | $256K | 132,521 |
| 2016-11-15 | Lee Howard Director | Sale | −17,994 | $20.76 | $374K | 114,527 |
| 2016-11-15 | Lee Howard Director | Option exercise · Stock Option (right to buy) | −17,994 | 0 |
Page 64 of 81 · 1,602 trades